Markku Miettinen

7PUBLICATIONS
119CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 07, 2025
Spatial Analysis of Hereditary Diffuse Gastric Cancer Reveals Indolent Phenotype of Signet Ring Cell Precursors.

Amber F Gallanis, Lauren A Gamble, Cihan Oguz

|Jan 17, 2025
Head and neck paraganglioma in Pacak-Zhuang syndrome.

Jared S Rosenblum, Yasemin Cole, Danielle Dang

|Nov 15, 2023
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.

Shadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero

|Sep 14, 2023
Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis.

Benjamin L Green, Lauren A Gamble, Laurence P Diggs

|Jul 03, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.

Srivandana Akshintala, R Taylor Sundby, Donna Bernstein

|Oct 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.

John A Ligon, R Taylor Sundby, Mary F Wedekind

Pageof 2